GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Masimo Corp (NAS:MASI) » Definitions » Revenue
中文

Masimo (Masimo) Revenue

: $2,048 Mil (TTM As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

Masimo's revenue for the three months ended in Dec. 2023 was $549 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $2,048 Mil. Masimo's Revenue per Share for the three months ended in Dec. 2023 was $10.20. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $37.84.

Warning Sign:

Masimo Corp revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Masimo was 2.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 24.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 22.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Masimo's highest 3-Year average Revenue per Share Growth Rate was 30.90% per year. The lowest was -19.30% per year. And the median was 12.10% per year.


Masimo Revenue Historical Data

The historical data trend for Masimo's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Masimo Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 937.84 1,143.70 1,239.20 2,035.80 2,048.10

Masimo Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 617.00 565.00 455.30 478.90 548.90

Competitive Comparison

For the Medical Devices subindustry, Masimo's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Masimo Revenue Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Masimo's Revenue distribution charts can be found below:

* The bar in red indicates where Masimo's Revenue falls into.



Masimo Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Masimo  (NAS:MASI) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Masimo Revenue Related Terms

Thank you for viewing the detailed overview of Masimo's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Masimo (Masimo) Business Description

Traded in Other Exchanges
Address
52 Discovery, Irvine, CA, USA, 92618
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Executives
Rolf A Classon director C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Politan Capital Management Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Partners Gp Llc other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Quentin Koffey other: Director by deputization POLITAN CAPITAL MANAGEMENT LP, 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Politan Capital Management Lp other: Director by deputization 106 WEST 56TH STREET, 10TH FLOOR, NEW YORK NY 10019
Michelle Brennan director 1855 S. GRANT STREET, SAN MATEO CA 94402
Joe E Kiani director, officer: CEO and Chairman of the Board 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Hataishi officer: SVP, Chief Accounting Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Blair Tripodi officer: COO, Consumer Division C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Kevin P Duffy officer: President, Consumer 1 VIPER WAY, VISTA CA 92081
Adam Mikkelson director C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Tao Levy officer: EVP BUS DEV C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Micah W Young officer: EVP & Chief Financial Officer C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE CA 92618
Thomas Samuel Mcclenahan officer: EVP & GENERAL COUNSEL 40 PARKER, IRVINE CA 92618
Craig B Reynolds director 1046 MIDDLEBROOK WAY, KENESAW GA 30144

Masimo (Masimo) Headlines

From GuruFocus